Recombinant Bradyrhizobium japonicum UPF0317 protein blr2921 (blr2921)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its inclusion.
Synonyms
blr2921; Putative hydro-lyase blr2921; EC 4.2.1.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-271
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bradyrhizobium diazoefficiens (strain JCM 10833 / IAM 13628 / NBRC 14792 / USDA 110)
Target Names
blr2921
Target Protein Sequence
MTVLVAAQQT ETPDPLPSRQ ARLAYRGGEV GSTAGVAPGF VQGNLAILPA EYASAFHRFC QLNPKPCPII GMSDVGSPHI PALGADLDIR TDVPRYRVWR DGEVVDEPTD VTGYWRDDLV TFVLGCSFSF EEALLDEGMP IRHIEQNVRV PMYRTNIACG EAGPFAGPMV VSMRPFKPAD AIRAVQITSR YPAVHGAPVH LGHPHLIGIK DIAKPDYGDP VPVADDEIPV FWACGVTPQS VINAARLPFA ITHSPGLMLV TDLKNRTMAV I
Uniprot No.

Q&A

What is UPF0317 protein blr2921 from Bradyrhizobium japonicum?

The UPF0317 protein blr2921 is a protein encoded by the blr2921 gene in Bradyrhizobium japonicum, a gram-negative soil bacterium known for its nitrogen-fixing capabilities in symbiotic relationships with legumes, particularly soybeans. The UPF (Uncharacterized Protein Family) designation indicates that its precise function has not been fully characterized, though it belongs to a conserved protein family. While the protein's exact role remains under investigation, studies suggest it may be involved in metabolic processes related to B. japonicum's symbiotic nitrogen fixation capabilities .

The protein is part of B. japonicum's proteome, which undergoes significant changes during nodule development and nitrogen fixation processes. Research has shown that protein synthesis patterns in B. japonicum bacteroids change during symbiotic development, with protein synthesis declining about 60% between 14 and 20 days after planting - coinciding with increased nitrogen fixation activity . This correlation suggests that proteins like blr2921 may play roles in the metabolic shift toward nitrogen fixation.

Which expression systems are most suitable for producing recombinant blr2921 protein?

For optimal recombinant production of UPF0317 protein blr2921, E. coli and yeast expression systems generally offer the best combination of yield and production time efficiency . When selecting an expression system, researchers should consider several factors including protein complexity, required post-translational modifications, and intended experimental applications.

For applications requiring authentic post-translational modifications or when problems with protein folding arise in simpler systems, insect cell expression systems using baculovirus or mammalian cell expression may be necessary despite their lower yields and longer production times . The choice ultimately depends on the specific research requirements, particularly whether native-like activity is essential for downstream applications.

How does the choice of expression vector affect blr2921 production?

The selection of an appropriate expression vector significantly impacts recombinant blr2921 production through several key mechanisms. Copy number, promoter strength, and regulatory elements all contribute to expression outcomes and metabolic burden on the host cell .

Promoter selection is equally critical. For blr2921 expression, inducible promoter systems like T7, lac, or arabinose-inducible promoters offer control over expression timing and intensity. The T7 promoter system in E. coli BL21(DE3) strains provides particularly strong expression capabilities but may lead to inclusion body formation if expression rates exceed the cell's protein folding capacity .

Table 1: Comparison of Expression Vector Components for Recombinant Protein Production

ComponentOptionsCharacteristicsImpact on blr2921 Expression
Replication OriginpMB1'500-700 copies/cellHigher potential yield but increased metabolic burden
p15A~10 copies/cellModerate yield with reduced burden on host
PromoterT7Strong, highly inducibleMaximum expression but potential inclusion body formation
lacModerate strength, inducibleBalanced expression with reduced stress response
ArabinoseTight regulationFine control over expression levels
Fusion TagsHis-tagSmall size, metal affinityEfficient purification with minimal impact on folding
MBPEnhances solubilityImproved solubility for proteins prone to aggregation

How can researchers optimize induction conditions for maximum blr2921 yield?

Optimizing induction conditions for recombinant blr2921 requires systematic assessment of multiple parameters including induction timing, inducer concentration, post-induction temperature, and culture media composition. A methodical approach examining these variables will help maximize protein yield while maintaining proper folding and activity.

Inducer concentration should be carefully titrated to determine the optimal level. For IPTG-induced systems, concentrations between 0.1-2.0 mM are commonly tested, with 0.5 mM often providing a good starting point . Complete induction does not always correlate with maximum protein yield, as excessive production can trigger stress responses and proteolytic degradation. A detailed concentration gradient experiment is recommended to identify the optimal inducer level for blr2921 specifically.

Post-induction temperature plays a crucial role in balancing expression rate with proper protein folding. While standard growth at 37°C maximizes expression rate, reducing temperature to 16-30°C after induction often improves soluble protein yields by slowing production and allowing more time for proper folding. For blr2921, researchers should test a range of post-induction temperatures (37°C, 30°C, 25°C, and 18°C) with extended expression times at lower temperatures to compensate for slower production rates.

What purification strategies are most effective for recombinant blr2921?

Developing an effective purification strategy for recombinant blr2921 requires consideration of the protein's physiochemical properties and fusion tag selection. A multi-step purification approach typically yields the highest purity while maintaining protein activity.

The initial capture step should leverage affinity chromatography based on the fusion tag incorporated into the recombinant construct. For blr2921, a polyhistidine tag (His-tag) allows for efficient immobilized metal affinity chromatography (IMAC) purification using Ni-NTA or Co-NTA resins . This approach provides good selectivity while maintaining mild elution conditions (imidazole gradient) that preserve protein activity. Alternative tags such as MBP (maltose-binding protein) can improve solubility for difficult-to-express proteins while enabling affinity purification using amylose resin.

Following the initial affinity step, size exclusion chromatography (SEC) serves as an effective polishing step to separate monomeric blr2921 from aggregates and remaining contaminants. SEC simultaneously allows buffer exchange into a stabilizing formulation optimized for downstream applications. For applications requiring especially high purity, an intermediate ion exchange chromatography step can be incorporated between affinity and size exclusion steps.

Throughout the purification process, protein stability should be monitored and maintained. For blr2921, buffers containing 20-50 mM Tris or phosphate at pH 7.0-8.0 with 100-300 mM NaCl provide a good starting point for maintaining stability. Addition of 5-10% glycerol and 1-5 mM DTT or TCEP may further improve stability if the protein contains cysteine residues.

How can researchers assess the functional activity of purified recombinant blr2921?

Assessing the functional activity of purified recombinant blr2921 presents a particular challenge due to its status as a protein with incompletely characterized function (UPF designation). Several complementary approaches should be employed to establish proper folding and potential functional activity.

Biophysical characterization forms the foundation of quality assessment. Circular dichroism (CD) spectroscopy can verify proper secondary structure formation, while thermal shift assays indicate protein stability and can be used to optimize buffer conditions. Size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) confirms the oligomeric state and homogeneity. These techniques collectively establish whether the recombinant protein has adopted a stable, well-folded conformation resembling the native state.

For functional analysis, researchers should leverage knowledge about Bradyrhizobium japonicum's biology and the protein's predicted properties. As B. japonicum's protein synthesis patterns change during nodule development and nitrogen fixation , assessing potential roles in these processes may provide functional insights. This could involve testing interactions with other B. japonicum proteins known to be involved in symbiosis or nitrogen fixation through co-immunoprecipitation or pull-down assays.

Comparative studies can also provide valuable information. Since blr2921 belongs to the UPF0317 protein family, which likely has conserved functions across species, complementation studies in model organisms with homologous gene knockouts might reveal functional roles. Additionally, structural analysis through X-ray crystallography or cryo-EM could identify structural motifs that suggest potential molecular functions.

How does metabolic burden impact recombinant blr2921 expression and what strategies can mitigate these effects?

Metabolic burden represents a significant challenge in recombinant protein production, particularly for high-level expression systems. For blr2921 production, metabolic burden manifests as reduced growth rates, decreased protein synthesis capacity, and potentially compromised protein quality due to resource limitations within the host cell .

The primary contributors to metabolic burden include plasmid maintenance, transcription of foreign genes, and translation of the recombinant protein. Research has demonstrated that the diversion of cellular resources toward foreign protein production can deplete the essential precursors needed for host cell maintenance . This depletion creates a negative feedback loop where compromised cellular health further reduces recombinant protein yields.

Several strategic approaches can mitigate metabolic burden effects when expressing blr2921:

What approaches can improve solubility and proper folding of recombinant blr2921?

Achieving proper folding and maintaining solubility of recombinant blr2921 requires addressing several potential obstacles through targeted interventions at the construct design, expression, and purification stages.

At the construct design level, fusion partners can dramatically improve solubility. Maltose-binding protein (MBP), thioredoxin (TrxA), and N-utilization substance A (NusA) tags have demonstrated superior solubility enhancement compared to smaller tags . For particularly challenging expression cases, dual fusion tags (e.g., His-MBP-target protein) can provide both solubility enhancement and purification capabilities. Additionally, codon optimization for the expression host can prevent translational pausing that may interfere with proper co-translational folding.

Expression conditions significantly impact folding outcomes. Lowering post-induction temperature to 16-25°C slows translation, allowing more time for proper folding while reducing the rate of aggregation-prone intermediates. Supporting this approach, adding rare tRNA supplementation in appropriate hosts helps maintain consistent translation rates across the entire sequence. For proteins requiring disulfide bonds, expression in specialized strains like E. coli Origami™ with oxidizing cytoplasmic environments may be beneficial.

Co-expression with molecular chaperones represents another powerful strategy. The GroEL/GroES system, DnaK/DnaJ/GrpE complex, or trigger factor can be co-expressed to assist with proper folding of recombinant proteins. Research has shown that matching the chaperone system to the specific folding challenges of the target protein can significantly improve soluble yields .

How can researchers investigate potential protein-protein interactions of blr2921 in the context of B. japonicum symbiosis?

Investigating protein-protein interactions (PPIs) of blr2921 in the context of B. japonicum symbiosis requires a multi-faceted approach that integrates in vitro, in vivo, and computational methods to build a comprehensive interaction network.

For initial screening of potential interaction partners, affinity purification coupled with mass spectrometry (AP-MS) provides a valuable discovery platform. In this approach, epitope-tagged recombinant blr2921 is expressed in B. japonicum under relevant physiological conditions (such as during nodule formation or nitrogen fixation) . After crosslinking to stabilize transient interactions, the protein complex is purified via the affinity tag, and co-purifying proteins are identified through mass spectrometry. This technique can reveal the broader interactome of blr2921 during symbiotic processes.

To validate and characterize specific interactions identified through screening, targeted methods such as bioluminescence resonance energy transfer (BRET) or fluorescence resonance energy transfer (FRET) allow monitoring of protein interactions in living cells. These approaches involve tagging blr2921 and its potential interaction partner with complementary fluorescent or luminescent proteins. Interaction is detected through energy transfer between tags when proteins come into proximity, providing real-time evidence of interaction in physiologically relevant conditions.

For detailed mechanistic studies, surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) can determine binding affinities, kinetics, and thermodynamic parameters of blr2921 interactions with specific partners. These quantitative measurements help distinguish between high-affinity specific interactions and low-affinity transient associations, providing crucial context for understanding blr2921's functional role.

The timing of protein interactions relative to symbiotic development is particularly important given the documented changes in B. japonicum protein synthesis during nodule development . Temporal profiling of the blr2921 interactome across different stages of symbiosis can reveal how its interaction network evolves during the transition from free-living to symbiotic states. This temporal dimension is essential for understanding the protein's role in the complex process of establishing and maintaining nitrogen-fixing symbiosis.

What are common issues encountered during blr2921 expression and how can they be addressed?

Researchers working with recombinant blr2921 frequently encounter several expression challenges that require systematic troubleshooting approaches. By identifying the specific nature of the expression problem, appropriate interventions can be implemented to improve outcomes.

Low expression levels often result from suboptimal codon usage, particularly when expressing bacterial proteins in heterologous systems. Analysis of the blr2921 sequence for rare codons in the expression host may reveal potential translational bottlenecks. Addressing this issue through codon optimization or supplementation with rare tRNA-encoding plasmids (such as pRARE in E. coli systems) can significantly enhance expression levels . Additionally, evaluating different combinations of promoters and ribosome binding sites can identify constructs with improved translation initiation efficiency.

Protein aggregation and inclusion body formation represent another common challenge. This often occurs when expression rates exceed the cell's capacity for proper protein folding. Beyond the previously discussed approaches of temperature reduction and chaperone co-expression, solubility can be improved by supplementing the growth medium with chemical chaperones like sorbitol, glycine betaine, or 4-phenylbutyric acid. These compounds create a more favorable environment for protein folding within the cytoplasm.

Proteolytic degradation may occur if the recombinant protein is recognized as foreign or improperly folded by host cell proteases. This can be addressed by using protease-deficient host strains, adding protease inhibitors during purification, or modifying the construct to remove protease recognition sites while preserving protein function. Additionally, targeting the protein to different cellular compartments (periplasm vs. cytoplasm) may provide a more suitable environment with reduced proteolytic activity.

Table 2: Troubleshooting Strategies for Common Expression Issues

ProblemPotential CausesSolutionsImplementation Notes
Low expressionRare codonsCodon optimizationAnalyze CAI for host system
Weak translation initiationModify RBSTest Shine-Dalgarno sequence variants
Promoter leakinessSwitch promoter systemConsider T7lac for tighter control
Inclusion bodiesRapid expression rateLower temperatureTypically 16-25°C post-induction
Improper foldingCo-express chaperonesGroEL/GroES or DnaK/DnaJ/GrpE
Hydrophobic regionsAdd solubility tagMBP or SUMO fusion
ProteolysisHost proteasesProtease-deficient strainsBL21(DE3) derivatives
Exposed cleavage sitesProtein engineeringConservative mutations at vulnerable sites
Long expression timeOptimize harvest timingMonitor expression time course

How can researchers optimize purification to address blr2921-specific challenges?

Optimizing purification protocols for recombinant blr2921 requires addressing protein-specific challenges throughout the isolation process. A tailored approach considering the protein's unique properties will maximize both yield and activity retention.

Buffer optimization represents a critical first step in developing an effective purification strategy. For initial screening, a buffer matrix examining pH ranges (6.0-9.0), salt concentrations (0-500 mM NaCl), and stabilizing additives (glycerol, reducing agents, and detergents) should be established. Thermal shift assays using differential scanning fluorimetry provide a high-throughput method to identify conditions that maximize protein stability. These optimized buffer conditions should then be implemented throughout the purification process, from cell lysis to final storage.

For affinity chromatography steps, several parameters can be adjusted to improve outcomes with blr2921. If using His-tag purification, different metal ions (Ni2+, Co2+, Cu2+) in the IMAC resin can alter selectivity and binding strength. Cobalt resins often provide higher purity but lower yield compared to nickel resins. Additionally, optimizing imidazole concentrations in wash and elution buffers prevents non-specific binding while ensuring complete target protein recovery. A stepped gradient with 3-4 imidazole concentrations often provides better separation than a simple wash/elute approach.

To address potential aggregation during purification, size exclusion chromatography (SEC) buffer conditions can be refined to include stabilizing agents specific to blr2921. Dynamic light scattering (DLS) measurements between purification steps provide valuable feedback on aggregation status, allowing buffer adjustments before proceeding to subsequent purification stages. For proteins showing concentration-dependent aggregation, dilute purification followed by gentle concentration using appropriate molecular weight cutoff filters may preserve the monomeric state.

What methods can verify proper folding and structural integrity of recombinant blr2921?

Verifying proper folding and structural integrity of recombinant blr2921 requires a comprehensive suite of analytical techniques that examine different aspects of protein structure and stability. A multi-method approach provides complementary data that collectively confirms native-like conformation.

Circular dichroism (CD) spectroscopy serves as an essential first-line technique for assessing secondary structure. Far-UV CD spectra (190-260 nm) reveal characteristic patterns for α-helical, β-sheet, and random coil elements, allowing comparison with predicted secondary structure based on sequence analysis or homology models. This technique provides rapid feedback on whether the recombinant protein contains the expected structural elements, though it lacks atomistic resolution.

Fluorescence spectroscopy offers insights into tertiary structure through the intrinsic fluorescence of aromatic residues, particularly tryptophan. The emission maximum of tryptophan residues shifts depending on their local environment - buried residues in properly folded proteins typically exhibit blue-shifted emission compared to exposed residues in unfolded states. For blr2921, comparing intrinsic fluorescence spectra between native and denaturing conditions can reveal whether the recombinant protein achieves proper tertiary folding.

Limited proteolysis combined with mass spectrometry provides structural information by identifying protease-resistant domains characteristic of well-folded proteins. This approach involves controlled digestion with proteases like trypsin or chymotrypsin, followed by analysis of the resulting fragments. Properly folded domains typically produce distinct, reproducible fragmentation patterns, while misfolded regions undergo more extensive digestion. The pattern of protected fragments can be compared against structural predictions to verify domain organization.

How can recombinant blr2921 be used to study B. japonicum symbiotic relationships?

Recombinant blr2921 provides a valuable tool for investigating the molecular mechanisms underlying B. japonicum's symbiotic relationships with legume hosts. By combining recombinant protein approaches with in vivo studies, researchers can elucidate the protein's potential roles in symbiosis establishment and nitrogen fixation.

Protein localization studies represent a fundamental application for recombinant blr2921. By generating antibodies against the purified recombinant protein, immunolocalization can track blr2921's distribution within bacterial cells and symbiotic nodules at different developmental stages. This approach can determine whether the protein's localization changes during the transition from free-living to bacteroid states, providing clues about its function. Additionally, expressing fluorescently-tagged versions in B. japonicum allows real-time tracking of protein dynamics during nodule development and nitrogen fixation .

Transcriptional regulation analysis using recombinant blr2921 can reveal integration points with known symbiosis pathways. Chromatin immunoprecipitation (ChIP) experiments with the recombinant protein can identify potential DNA binding sites if blr2921 functions as a transcriptional regulator. Alternatively, if the protein is involved in post-transcriptional processes, RNA immunoprecipitation (RIP) approaches can identify associated transcripts. These methods can establish whether blr2921 regulates genes known to be important during nodulation or nitrogen fixation.

The correlation between reduced protein synthesis and increased nitrogen fixation activity in B. japonicum bacteroids suggests potential metabolic regulatory roles . Recombinant blr2921 enables biochemical assays to test interactions with key metabolic enzymes or regulatory proteins involved in this metabolic shift. In vitro reconstitution experiments combining purified blr2921 with candidate pathway components can determine whether the protein directly influences enzymatic activities related to nitrogen fixation.

What comparative approaches between homologous UPF0317 proteins could reveal about blr2921 function?

Comparative studies leveraging evolutionary relationships between UPF0317 family proteins across different species can provide crucial insights into blr2921's function through the principle that structural and functional conservation often coincide.

Structural comparison between homologs provides another powerful approach. Determining the crystal or cryo-EM structure of recombinant blr2921 and comparing it with structures of homologous proteins (if available) can reveal conserved structural motifs associated with specific biochemical functions. Even in the absence of experimental structures, homology modeling based on related proteins with known structures can generate testable hypotheses about functional domains within blr2921.

Heterologous complementation studies offer functional insights through cross-species rescue experiments. If genes encoding UPF0317 family proteins have been disrupted in model organisms with resulting phenotypes, testing whether blr2921 can rescue these phenotypes can demonstrate functional conservation. This approach has particular value for proteins with unknown functions, as it connects the protein to observable phenotypes and cellular processes.

How might structural biology approaches enhance our understanding of blr2921?

Structural biology approaches provide essential insights into blr2921's molecular function by revealing its three-dimensional architecture, identifying functional domains, and elucidating potential interaction surfaces. These approaches complement biochemical and genetic studies by providing atomistic details that inform mechanistic hypotheses.

X-ray crystallography offers high-resolution structural determination capable of revealing detailed molecular features. For blr2921, crystallization trials should explore a matrix of conditions including various precipitants, buffers, additives, and protein concentrations. Crystallization of the protein both alone and in complex with potential binding partners (identified through interaction studies) can reveal conformational changes upon binding that suggest functional mechanisms. The resulting structures can identify catalytic sites if blr2921 possesses enzymatic activity, or interaction interfaces if it functions through protein-protein interactions.

Cryo-electron microscopy (cryo-EM) provides an alternative structural approach particularly valuable for proteins resistant to crystallization or those that form larger complexes. While traditionally applied to larger assemblies, advances in single-particle cryo-EM now enable structure determination of smaller proteins. For blr2921, this approach can visualize the protein in different functional states or in complex with interaction partners under near-native conditions without crystal packing constraints.

NMR spectroscopy complements static structural methods by providing dynamics information. For blr2921, NMR can identify flexible regions that may function in recognition or undergo conformational changes during function. Additionally, NMR titration experiments can map binding interfaces with interaction partners at residue-level resolution. This approach is particularly valuable for characterizing weak or transient interactions that might be difficult to capture through crystallography.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.